花旗:上調中聯重科(1157.HK)目標價至6.49港元 評級“買入”
花旗發表報告指,中聯重科(01157.HK)第三季盈利按年升106%至9.04億元人民幣,當中核心盈利升111%至6.52億元人民幣,首三季核心盈利更按年升189%,符合該行預期。而且該公司第三季毛利率維持在29.4%的水平,息税前利潤率亦增2.52個百分點,主因銷售及營運成本有效控制。
該行上調中聯重科2019至2021年盈利預測9%/1%/1%,以反映混凝土機械及起重機的銷售增加。目標價相應由5.95港元上調至6.49港元,維持“買入”評級,更是該行於中國工程機械板塊的首選。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.